Afficher la notice abrégée

Performing pharmacoepidemiological studies using the French health insurance data warehouse (SNDS): How to translate guidelines into practice

dc.rights.licenseopenen_US
hal.structure.identifierBordeaux population health [BPH]
dc.contributor.authorDE GERMAY, Sibylle
dc.contributor.authorCONTE, Cecile
dc.contributor.authorMICALLEF, Joelle
dc.contributor.authorBOUQUET, Emilie
dc.contributor.authorCHOUCHANA, Laurent
dc.contributor.authorLAFAURIE, Margaux
hal.structure.identifierBordeaux population health [BPH]
dc.contributor.authorPARIENTE, Antoine
dc.date.accessioned2024-05-15T08:38:43Z
dc.date.available2024-05-15T08:38:43Z
dc.date.issued2023-11-01
dc.identifier.issn1958-5578en_US
dc.identifier.urihttps://oskar-bordeaux.fr/handle/20.500.12278/199860
dc.description.abstractEnThe French health insurance data warehouse named SNDS is one of the largest medico-administrative in the world allowing for powerful pharmacoepidemiological studies, based on real-life data collected prospectively. In addition to the absolute necessity of a strong pharmacological rationale, recommendations have been thought to improve the quality of pharmacoepidemiological studies. These guidelines emphasize the importance of an accurate definition of the study population, outcome and exposure, especially for studies performed on medico-administrative databases. Compliance with certain guidelines, particularly those concerning the identification of a specific population or an outcome and the definition of risk periods or exposure periods, may be difficult when performing studies on the SNDS because of its structure and the nature of the data recorded. The objective of this article is to provide advice for the conduct of pharmacoepidemiological studies according to the recommendations when using the SNDS, given its specificities. The performing of reliable studies from this rich but complex data warehouse requires the expertise of researchers with deep knowledge both in the SNDS and in pharmacological reasoning.
dc.language.isoENen_US
dc.subject.enFrench National Health Data System
dc.subject.enGuidelines
dc.subject.enPharmacoepidemiology
dc.title.enPerforming pharmacoepidemiological studies using the French health insurance data warehouse (SNDS): How to translate guidelines into practice
dc.title.alternativeTherapieen_US
dc.typeArticle de revueen_US
dc.identifier.doi10.1016/j.therap.2023.01.009en_US
dc.subject.halSciences du Vivant [q-bio]/Santé publique et épidémiologieen_US
dc.identifier.pubmed36841656en_US
bordeaux.journalTherapiesen_US
bordeaux.page679-689en_US
bordeaux.volume78en_US
bordeaux.hal.laboratoriesBordeaux Population Health Research Center (BPH) - UMR 1219en_US
bordeaux.issue6en_US
bordeaux.institutionUniversité de Bordeauxen_US
bordeaux.institutionINSERMen_US
bordeaux.teamAHEAD_BPHen_US
bordeaux.peerReviewedouien_US
bordeaux.inpressnonen_US
hal.identifierhal-04575719
hal.version1
hal.date.transferred2024-05-15T08:38:45Z
hal.popularnonen_US
hal.audienceInternationaleen_US
hal.exporttrue
dc.rights.ccPas de Licence CCen_US
bordeaux.COinSctx_ver=Z39.88-2004&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.jtitle=Therapies&rft.date=2023-11-01&rft.volume=78&rft.issue=6&rft.spage=679-689&rft.epage=679-689&rft.eissn=1958-5578&rft.issn=1958-5578&rft.au=DE%20GERMAY,%20Sibylle&CONTE,%20Cecile&MICALLEF,%20Joelle&BOUQUET,%20Emilie&CHOUCHANA,%20Laurent&rft.genre=article


Fichier(s) constituant ce document

FichiersTailleFormatVue

Il n'y a pas de fichiers associés à ce document.

Ce document figure dans la(les) collection(s) suivante(s)

Afficher la notice abrégée